The United States Supreme Court has provided further clarification on the judicial approach regarding policy reversals by administrative agencies when there is a change in the presidential administration. This development follows the court’s recent decision in a case involving the Food and Drug Administration (FDA) and their rejection of applications to market flavored vaping products.
On April 2, the justices formalized a previously recognized method that delineates the required actions an agency must undertake to justify significant policy shifts. This clarification arises after the court’s significant ruling in Loper Bright v Raimondo, where it addressed deference to administrative agencies by effectively overturning the long-held Chevron doctrine. The full details of the Supreme Court’s decision and its implications can be accessed through Bloomberg Law.
Christopher Walker, a law professor at the University of Michigan, emphasized that this ruling serves to address a “missing piece,” enhancing clarity in the realm of administrative law. The decision holds particular significance for regulated parties who require sufficient notice and rationale from agencies amid changing regulatory landscapes.
This legal development will resonate across administrative law practices, with implications for both corporate legal departments and law firms engaging with regulatory compliance and agency policy. The court’s ruling underscores the necessity for transparent and robust justification by agencies during policy transitions, thus ensuring accountability and predictability within the regulatory framework.